NICE Secures Breakthrough HTA Decision for Prostate Cancer
NICE issues breakthrough HTA decision on Bayer’s prostate cancer therapy.
Month: October 2025
NICE accelerates breakthrough framework for complex liver diseases
NICE drives innovation, reshaping MASH evaluations with transformative guidance.
Novartis secures triumphant $12 billion takeover of Avidity
The billion-dollar acquisition advances Avidity’s RNA platform with momentum.
Biogen Secures Breakthrough Edge in Immunology with $1B Vanqua Buy
Biogen strengthens Immunology pipeline through $1B Vanqua acquisition deal.
Sanofi Secures Breakthrough FDA Review for Tzield
Sanofi’s Tzield gains FDA review for stage 3 T1D.